Metropolis Health signs pact to buy Shraddha Diagnostics

Ameera Shah
6 122
Ms Ameera Shah, MD, Metropolis Healthcare

DTMT Network
Leading pan-India pathology specialist Metropolis Healthcare has signed a binding pact to acquire Ahmedabad-based Shraddha Diagnostics.

Metropolis has expanded its lab footprint in nine cities and towns including Ahmedabad, Surat, Baroda, Mehsana, Rajkot, Navsari, Jamnagar, Bharuch and Gandhidham. The company has 300 patient service network centers across the Gujarat and services over 1500+ clients.

Ms Ameera Shah, Managing Director, Metropolis Healthcare, said, “With this acquisition, we are aiming to gain profitable market share by building better leadership, operational capabilities, and expanding our test menu.”

She pointed out, “Our immediate focus would be to fully integrate and modernize these laboratories and in terms of diagnosis, deliver on our promise of integrity, empathy, and accuracy.”

Metropolis, since 2002, has successfully used its brand strength to established large networks through acquisitions in Chennai, Rajkot, Surat, Bangalore, Pune as well as outside India, according to a company statement.

The company offers a comprehensive range of 3,487 clinical laboratory tests and 530 profiles that includes advanced tests in diagnosis of cancer, neurological disorders, infectious diseases and an array of genetic abnormalities, it said.


  1. Be first to post your comments

Your Comment

Your email address will not be published. Required fields are marked *


Back to Top